Actionable bottom-up long/short Insights on equities

Equity Bottom-Up

Asset allocation and country/region investment strategy

Cross Asset Strategy

United Kingdom

Australia

United States

Denmark

Canada

Chile

Singapore

Physiomics plc develops computer simulation technology to understand and predict patient responses to pharmaceuticals.

Coro Energy PLC provides exploration services. The Company offers activities in the fields of gas and oil. Coro Energy serves customers worldwide.

Petards Group PLC designs and provides a range of electronic and security products and systems. The company supplies customers in central and local government, as well as in the commercial sector and commercial customers, primarily in the United Kingdom. Petards Group PLC operates through two principal subsidiaries, Petards Datax and Petards International.

Abingdon Health Plc is a technology-enabled lateral flow diagnostics company. The Company offers lateral flow assay development and smartphone reader solutions alongside Europe's largest rapid test manufacturing capacity. Abingdon Health serves customers worldwide.

CyanConnode Holdings PLC designs and develops narrowband RF mesh networks for Internet of things communications. The Company offers long-range, low-power, and end-to-end networking solutions and applications. CyanConnode Holdings serves customers in the United Kingdom.

Fusion Antibodies Ltd operates as a bio-technology company. The Company develops antibodies for therapeutic drug and diagnostic applications. Fusion Antibodies also renders antibody class switching, stable cell line development, mammalian transient and bacterial protein expression, custom monoclonal antibody production, and sequencing services.

Aptamer Group PLC operates as a biotechnology company. The Company focuses on the development of aptamer technologies and develops nucleic acid aptamers for use in research and development, biomarker discovery, diagnostics, and therapeutic developments. Aptamer Group serves customers in the United Kingdom.

Safestay PLC owns and operates contemporary hostels in London.

First Tin Limited provides mining services. The Company focuses on tin production from zero waste mines in Germany and Australia. First Tin serves customers worldwide.

Shield Therapeutics plc, a specialty pharmaceutical company, focuses on the development and commercialization of secondary care-focused pharmaceuticals. Its lead product is Feraccru, a novel therapy for the treatment of iron deficiency anaemia (IDA) in patients with inflammatory bowel disease. Its products pipeline includes PT20, a novel iron-based phosphate binder for the treatment of hyperphosphatemia related to chronic kidney disease (CKD); PT30 and PT40 that are intravenous iron formulations; and Feraccru to treat patients with IDA related to CKD and other indications. The company was founded in 2008 and is based in Gateshead Quays, the United Kingdom.

Information Technology

Materials

Industrials

Health Care

Energy

Consumer Discretionary

Financials

Real Estate

Consumer Staples

Communication Services

Hybridan

Our passion is raising growth capital for exciting, fast growth companies that want to take their business to the next level. We raise capital for companies both listed and unlisted in the most efficient manner possible and pride ourselves as being one of the few consistently profitable broking firms in the City. This has been achieved through a highly disciplined approach when seeking to create both corporate and institutional relationships.

Your Partner for Growth

Your Partner for Growth, Hybridan

Hybridan Small Cap Feast is "Our daily digest of news from UK Small Caps". 

Hybridan Friday Takeaway is "This will delve a little deeper on individual companies and focus on non-house stocks under £200m market capitalisation to help raise awareness". 

Corporate Research is our equity research on smaller companies

Hybridan
Your Partner for Growth
• Hybridan

Top Sectors

Top Verticals

Top Entities

Top Countries